3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Lung Neoplasms
2
Urinary Bladder Neoplasms
1
Prostatic Neoplasms
1
Postoperative Nausea and Vomiting
1
Postoperative Complications
1
Pancreatic Adenocarcinoma
1
Pain, Postoperative
1
Multiple Pulmonary Nodules
1
Glioma
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Airway Management
1
Interventions
Dexamethasone
5
ramosetron
3
Ondansetron
2
Calcium Dobesilate
2
Acupuncture Therapy
2
phenazine
1
esmolol
1
Therapeutics
1
Surveys and Questionnaires
1
Sufentanil
1
Promethazine
1
Postoperative Care
1
Olanzapine
1
Gelatin
1
Fentanyl
1
Famotidine
1
Electroacupuncture
1
Electric Stimulation Therapy
1
Electric Stimulation
1
Diphenhydramine
1
Dexmedetomidine
1
Aprepitant
1
Antiemetics
1
Anesthesia, General
1
Anesthesia
1
Adrenergic beta-Antagonists
1
((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Postoperative Nausea and Vomiting
×
Anesthesia
×
Clear all
NCT03271749
2020-12-21
PROSM
Hospital Santa Marcelina
Phase NA
Not yet recruiting
200 enrolled